PCSA News

Latest breaking news and updates for PCSA stock.

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for...

How do investors and analysts view the combination of biotech funding with crypto treasury initiatives? What is the expected impact on the stock price in the short term and long term? Will the crypto treasury strategy be disclosed in SEC filings and how will it be accounted for?

Funding

about 1 month ago

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (the “Company”), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) ther...

Financing

3 months ago